Humana Inc. (HUM) Holdings Cut by Victory Capital Management Inc.
Victory Capital Management Inc. cut its holdings in Humana Inc. (NYSE:HUM) by 8.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,485 shares of the insurance provider’s stock after selling 232 shares during the quarter. Victory Capital Management Inc.’s holdings in Humana were worth $598,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of HUM. Guardian Life Insurance Co. of America lifted its stake in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the period. Independent Portfolio Consultants Inc. lifted its stake in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after buying an additional 94 shares during the period. Point72 Asia Hong Kong Ltd acquired a new position in Humana in the first quarter valued at approximately $128,000. Westbourne Investment Advisors Inc. acquired a new position in Humana in the second quarter valued at approximately $205,000. Finally, Hengehold Capital Management LLC acquired a new position in Humana in the second quarter valued at approximately $209,000. 95.12% of the stock is currently owned by hedge funds and other institutional investors.
Humana Inc. (NYSE:HUM) opened at 249.28 on Monday. The company has a market cap of $36.03 billion, a P/E ratio of 20.51 and a beta of 0.87. The firm has a 50-day moving average price of $250.25 and a 200-day moving average price of $231.50. Humana Inc. has a 52 week low of $163.50 and a 52 week high of $259.76.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter in the previous year, the company posted $2.30 earnings per share. Equities research analysts anticipate that Humana Inc. will post $11.55 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Tuesday, August 29th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s payout ratio is currently 13.06%.
A number of equities analysts have recently weighed in on the company. UBS AG reaffirmed a “neutral” rating and set a $250.00 target price (up from $237.00) on shares of Humana in a research report on Wednesday, August 9th. Zacks Investment Research lowered Humana from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Cowen and Company reaffirmed a “buy” rating and set a $230.00 target price on shares of Humana in a research report on Friday, July 14th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a research report on Thursday, August 10th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $223.00 target price (up from $200.00) on shares of Humana in a research report on Thursday, August 3rd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $244.35.
In other Humana news, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the completion of the sale, the senior vice president now owns 14,258 shares of the company’s stock, valued at $3,421,920. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider William Kevin Fleming sold 3,071 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total value of $770,759.58. Following the sale, the insider now directly owns 7,681 shares of the company’s stock, valued at approximately $1,927,777.38. The disclosure for this sale can be found here. Insiders sold 60,566 shares of company stock valued at $15,326,746 in the last ninety days. 0.80% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Humana Inc. (HUM) Holdings Cut by Victory Capital Management Inc.” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://www.thecerbatgem.com/2017/09/18/humana-inc-hum-holdings-cut-by-victory-capital-management-inc.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.